Fix the antibiotics pipeline

Nature. 2011 Apr 7;472(7341):32. doi: 10.1038/472032a.
No abstract available

MeSH terms

  • Anti-Bacterial Agents* / biosynthesis
  • Anti-Bacterial Agents* / economics
  • Clinical Trials, Phase III as Topic / economics
  • Drug Design
  • Drug Discovery / economics
  • Drug Discovery / legislation & jurisprudence
  • Drug Discovery / methods*
  • Drug Discovery / trends*
  • Drug Industry / economics
  • Drug Industry / legislation & jurisprudence
  • Drug Industry / trends*
  • Drug Resistance, Bacterial*
  • Federal Government
  • Humans
  • International Cooperation
  • Leadership
  • Models, Economic
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence

Substances

  • Anti-Bacterial Agents